Ethical aspects. It is the responsibility of the contractor to safeguard the rights and welfare of human subjects involved in research performed under this agreement, in accordance with the appropriate national code of ethics or legislation, if any, and in the absence thereof, the Helsinki Declaration and any subsequent amendments. Prior to commencing any such research, the contractor shall ensure that (a) the rights and welfare of the subjects involved in the research are adequately protected, (b) freely given informed consent has been obtained for all participants, (c) the balance between risk and potential benefits involved has been assessed and deemed acceptable by a panel of independent experts appointed by the contractor, and (d) any special national requirements have been met.
Ethical aspects. It is the responsibility of the Institution and the Principal Investigator to safeguard the rights and welfare of human subjects involved in research supported in whole or in part by funds from WHO, in accordance with the appropriate national code of ethics or legislation, if any, and in the absence thereof, the Helsinki Declaration and any subsequent amendments. 22 October 2022 can commence.
Ethical aspects. <3.8 – Ethical aspects of the proposal>
Ethical aspects. Ethical aspects related to collection and use of data in MULTI-STR3AM are mostly related to personal data, for example those collected in connection with stakeholder interviews, discussions with policy makers and names and for the purpose of newsletter signup. The collection and use of such data should be kept to a minimum and only on a “need to know” basis. With guidance from the Data Management Officer, each project partner is responsible for complying with their own Data Protection Policy and GDPR rules. Informed consent for data sharing and long-term preservation is included in questionnaires dealing with personal data. When personal data is collected from a given individual, the individual must receive adequate information concerning the aims and procedures of the data collection, processing, storage, protection, retention and destruction in writing to ensure they make an informed decision on whether to provide their data. At any given time, the person can withdraw their consent by writing directly to the Data Management Officer, whose contact details will be clearly stated along with the above- mentioned information.
Ethical aspects. According to the Annex 1 of Grant Agreement 814389, the SPIDER Consortium has taken into account all ethical issues listed in the H2020 participant portal for the call topic “Materials for future highly performant electrified vehicle batteries”. The consortium is committed to demonstrating research integrity, which means, in particular, avoiding falsification, plagiarism or other research misconduct. More precisely, all the activities carried out under the SPIDER project comply with ethical principles and relevant national, EU and international legislation, for example the Charter of Fundamental Rights of the European Union and the European Convention on Human Rights. The project does not involve research on humans, animals or cells. In any case, all the partners will follow their internal protocols to treat any material according to the national law and EU legislation. All chemical waste will be collected and processed by a central facility that respects regulations and environmental and health best practices. All waste will be recycled or appropriately disposed of.
Ethical aspects. The handling of the Protection of Personal Data (POPD) requirements in CREMLINplus are described in a dedicated deliverable (D11.2 and D11.3). Surveys conducted as part of CREMLINplus will treat personal data in compliance with GDPR. Personal data collected for them will be deleted, anonymized or aggregated.
Ethical aspects. The ethical aspects of collecting and storing data in MEESO are treated in three separate deliverables on ethics. These deliverables will include: - The procedures and criteria that will be used to identify/recruit research participants. - The informed consent procedures that will be implemented for the participation of humans. - Templates of the informed consent forms and information sheets covering the voluntary participation and data protection issues (in language and terms intelligible to the participants) must be kept on file (to be specified in the grant agreement). - The English version of the templates of the informed consent forms and information sheets. - Details on the experiments to be conducted and information on the procedures to ensure animal welfare and adherence to the Three Rs principle.
Ethical aspects. The Study will be conducted in full respect of human dignity and its fundamental rights as dictated by the "Treaty of Helsinki" and subsequent amendments, by the "Good Clinical Practice" (GCP) rules issued by the European Community and in accordance with all local laws and regulations concerning clinical trials.
Ethical aspects. The present chapter intends to provide and answer to a number of questions as: Are there any ethical or legal issues that can have an impact on data sharing? These can also be discussed in the context of the ethics review. If relevant, include references to ethics deliverables and ethics chapter in the Description of the Action (DoA). Is informed consent for data sharing and long term preservation included in questionnaires dealing with personal data? In this framework there is not any ethical issue but informed consent for data sharing will be collected if personal data will be needed from stakeholders feedback/info collection. 7 Other issues Details in relation to other national/funder/sectorial/departmental procedures for data management used by each partner are not herein presented as this is a public DMP release.
Ethical aspects. In a perfect world, the question whether gender diversity on board is relevant would not arise. A uniform distribution of talent between genders on board level would occur naturally (Langevoort, 2010). However, the imperfect world we are in compromises gender discrimination and unequal opportunities. This makes the issue of gender diversity on boards relevant at least from a social justice perspective. Xxxxx (2014) states that fairness, equal opportunity and making better use of the female pool of talent are key arguments to strive for gender balance on board. Additionally, boards of directors should see interest in including women at all societal levels and taking advantage of their skills to an equal extent to that of men (Nielsen, 2010). As stated by Xxxxxxxx and Xxxxxxx-Xxxx (2008), it is immoral for women to be excluded from corporate boards based on gender. In fact, gender equality besides being a fundamental right, should be considered as a desirable goal to achieve. As women still have a way to go to reach parity with men in the boardroom, they should be given the same opportunities as their male counterparts (Xxxxxxxx, 2016). Gender balance on board level is more than a moral duty or only a women issue, every company has a social responsibility as being part of society. In fact, having gender equality on board is an integral part of the corporate social responsibility of a company and might improve the company’s image (Deloitte, 2016).
